
11: To Infinity and Beyond
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Risk Revolution, a monthly series of the Voices in Validation, brought to you by the IVT Network. This series aims to advance the maturity of risk management practices within the industry, addressing topics that challenge quality professionals to seek opportunities to improve and advance how they perceive and manage risk.
Resources from this episode:
ISPE’s KM Good Practice Guide
T.U. Dublin’s: A Survey Report on the Current State of QRM and KM Integration
Knowledge As The Currency Of Managing Risk: A Novel Framework To Unite Quality Risk Management And Knowledge Management
Managing Knowledge and Risk – A Literature Review on the Interdependency of QRM and KM as ICH Q10 Enablers
Effective Knowledge Transfer During Biopharmaceutical Technology Transfer
Turning Knowledge Into an Asset in Pharmaceuticals – PODCAST
About Our Guest:
Marty Lipa
Marty Lipa is the Executive Director - Knowledge Management at Merck. Marty has over 27 years in the biopharmaceutical industry and has led the KM Center of Excellence for Merck manufacturing for the last 11 years. Marty has recently completed the requirements for his Ph.D. at TU Dublin, emphasizing KM and its connection to QRM.
Ce que les auditeurs disent de 11: To Infinity and Beyond
Moyenne des évaluations de clientsÉvaluations – Cliquez sur les onglets pour changer la source des évaluations.
Il n'y a pas encore de critiques pour ce titre.